Evidence map›Paper›PMID 33281167›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy.

Kenichi Yokota, Isao Kurihara, Yohji Matsusaka, Katsura Emoto, Tomoyuki Hishida, Takuma Oshida, Sakiko Kobayashi, Ayano Murai-Takeda, Kazutoshi Miyashita, Kohei Matsuda and 3 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kenichi YokotaDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Isao KuriharaDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Yohji MatsusakaDepartment of Nuclear Medicine, Saitama Medical University International Medical Center, Japan.
Katsura EmotoDepartment of Pathology, Keio University School of Medicine, Japan.
Tomoyuki HishidaDivision of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Japan.
Takuma OshidaDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Sakiko KobayashiDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Ayano Murai-TakedaDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Kazutoshi MiyashitaDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Kohei MatsudaDivision of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Japan.
Takahiro NakagomiDivision of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Japan.
Kosuke MatsudaDepartment of Pathology, Keio University School of Medicine, Japan.
Hiroshi ItohDepartment of Internal Medicine, Keio University School of Medicine, Japan.
Keio University · JPSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 71-year-old man complained of nausea and loss of appetite for eight months prior to admission. He was transported to a hospital with disorientation and diagnosed with primary hyperparathyroidism by laboratory examinations. However, ultrasonography, computed tomography, and technetium-99m labeled methoxyisobutyl isonitrile (

Indexed as

AdenomaParathyroid NeoplasmsAgedHumansMaleParathyroid GlandsRadionuclide ImagingRadiopharmaceuticalsReceptors, SomatostatinTechnetium Tc 99m SestamibiTomography, Emission-Computed, Single-PhotonRadiopharmaceuticalsReceptors, SomatostatinTechnetium Tc 99m Sestamibi111In-pentetreotide scintigraphyectopic parathyroid adenomaparathyroid hormoneprimary hyperparathyroidismsomatostatin receptor scintigraphy

Identifiers

PMID33281167
PMCPMC8188027
OpenAlexW3112882546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.